MUFG Securities EMEA plc Takes $2.96 Million Position in Amedisys, Inc. (NASDAQ:AMED)

Key Points

• MUFG Securities EMEA plc acquired a new stake in Amedisys, Inc., purchasing 32,000 shares valued at approximately $2.96 million.
• Amedisys reported a quarterly earnings per share of $1.54, surpassing the consensus estimate of $1.39, with revenue of $621.86 million during the quarter.
• Analysts forecast growth for Amedisys, with Wall Street ratings reflecting a shift from "strong-buy" to "buy," and a target price set at $100.00 by Royal Bank of Canada.

MUFG Securities EMEA plc acquired a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 32,000 shares of the health services provider's stock, valued at approximately $2,964,000. MUFG Securities EMEA plc owned 0.10% of Amedisys at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of AMED. Raymond James Financial Inc. purchased a new position in shares of Amedisys during the 4th quarter valued at approximately $215,000. Geode Capital Management LLC increased its holdings in shares of Amedisys by 1.0% during the 4th quarter. Geode Capital Management LLC now owns 573,020 shares of the health services provider's stock valued at $52,040,000 after purchasing an additional 5,915 shares in the last quarter. ExodusPoint Capital Management LP purchased a new position in shares of Amedisys during the 4th quarter valued at approximately $356,000. Resona Asset Management Co. Ltd. purchased a new position in shares of Amedisys during the 4th quarter valued at approximately $535,000. Finally, Wells Fargo & Company MN increased its holdings in shares of Amedisys by 4.7% during the 4th quarter. Wells Fargo & Company MN now owns 7,161 shares of the health services provider's stock valued at $650,000 after purchasing an additional 323 shares in the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Amedisys Price Performance

NASDAQ AMED traded down $0.01 on Wednesday, hitting $100.94. The company had a trading volume of 263,931 shares, compared to its average volume of 405,943. The company has a market capitalization of $3.32 billion, a PE ratio of 39.28, a PEG ratio of 1.34 and a beta of 0.89. The company's fifty day moving average price is $97.60 and its 200-day moving average price is $94.57. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.36 and a quick ratio of 1.36. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $101.01.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its earnings results on Tuesday, July 29th. The health services provider reported $1.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.15. Amedisys had a net margin of 3.56% and a return on equity of 12.91%. The company had revenue of $621.86 million for the quarter, compared to analysts' expectations of $614.61 million. During the same quarter in the previous year, the company posted $0.98 EPS. The firm's quarterly revenue was up 5.2% on a year-over-year basis. As a group, analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AMED has been the subject of several recent research reports. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $100.00 target price on shares of Amedisys in a report on Wednesday, April 16th. Wall Street Zen lowered shares of Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.